Articles by Disease (Ovarian Cancer)

Modulation of Cytotoxicity of Benzamide Riboside by Expression of NMN Adenylyltransferase

Journal: Current Medicinal Chemistry
Volume: 9
Page: 749-758
Author(s): Joel A. Yalowitz and Hiremagalur N. Jayaram

Antitumor Activity of Benzamide Riboside In Vitro and In Vivo

Journal: Current Medicinal Chemistry
Volume: 9
Page: 773-779
Author(s): Ladislav Novotny, Peter Rauko, Joel A. Yalowitz and Thomas Szekeres

Toxicity and Efficacy of Benzamide Riboside in Cancer Chemotherapy Models

Journal: Current Medicinal Chemistry
Volume: 9
Page: 787-792
Author(s): Hiremagalur N. Jayaram, Joel A. Yalowitz, Francisco Arguello, John F. Greene and Jr

Biomolecular Targets for Platinum Antitumor Drugs

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 2
Page: 103-111
Author(s): Rathindra N. Bose

Trypsin and Chymotrypsin Inhibitors in Insects and Gut Leeches

Journal: Current Pharmaceutical Design
Volume: 8
Page: 483-491
Author(s): Liliane Schoofs, Elke Clynen and Michel Salzet

Prospects for Anti-Neoplastic Therapies Based on Telomere Biology

Journal: Current Cancer Drug Targets
Volume: 2
Page: 1-17
Author(s): sheila A. Stewart and William C. Hahn

Integrins as Novel Drug Targets for Overcoming Innate Drug Resistance

Journal: Current Cancer Drug Targets
Volume: 2
Page: 37-43
Author(s): Jason S. Damiano

Sulfonamides and Sulfonylated Derivatives as Anticancer Agents

Journal: Current Cancer Drug Targets
Volume: 2
Page: 55-75
Author(s): Angela casini, Andrea Scozzafava, Antonio Mastrolorenzo and Claudiu T. Supuran

The Impact of Thrombopoietin on Clinical Practice

Journal: Current Pharmaceutical Design
Volume: 8
Page: 369-377
Author(s): Russell Basser

Design of Selectively Activated Anticancer Prodrugs: Elimination and Cyclization Strategies

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 2
Page: 155-185
Author(s): S. Papot, I. Tranoy, F. Tillequin, J. -C. Florent and J. -P. Gesson